KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 107 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 12.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,255,000 | +2.2% | 16,740 | +2.6% | 0.00% | 0.0% |
| Q2 2015 | $1,228,000 | +107.8% | 16,315 | +38.5% | 0.00% | 0.0% |
| Q1 2015 | $591,000 | +47.8% | 11,780 | +2.0% | 0.00% | 0.0% |
| Q4 2014 | $400,000 | +3.1% | 11,549 | -2.5% | 0.00% | 0.0% |
| Q3 2014 | $388,000 | -11.8% | 11,846 | +3.3% | 0.00% | 0.0% |
| Q2 2014 | $440,000 | +19.6% | 11,473 | +23.8% | 0.00% | 0.0% |
| Q1 2014 | $368,000 | +8.2% | 9,265 | +1.5% | 0.00% | 0.0% |
| Q4 2013 | $340,000 | -13.0% | 9,126 | +6.8% | 0.00% | 0.0% |
| Q3 2013 | $391,000 | +68.5% | 8,543 | -0.5% | 0.00% | – |
| Q2 2013 | $232,000 | – | 8,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,382,722 | $69,344,000 | 3.43% |
| Versant Venture Management, LLC | 70,376 | $3,529,356,000 | 3.10% |
| AlpInvest Partners B.V. | 29,731 | $1,491,000 | 2.79% |
| Partner Investment Management, L.P. | 29,178 | $1,463,000 | 2.20% |
| PFM Health Sciences, LP | 1,242,509 | $62,312,000 | 1.72% |
| Aureus Asset Management, LLC | 130,307 | $6,535,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 444,999 | $22,317,000 | 1.49% |
| HealthCor Management, L.P. | 425,000 | $21,314,000 | 1.02% |
| Redmile Group, LLC | 225,062 | $11,287,000 | 1.01% |
| REGENTATLANTIC CAPITAL LLC | 174,454 | $8,749,000 | 0.77% |